|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Neoadjuvant therapy for gastroesophageal adenocarcinoma显示文摘Gastric and esophageal adenocarcinomas are one of the main causes of cancer-related death worldwide. While the incidence of gastric adenocarcinoma is decreasing, the incidence of gastroesophageal junction adenocarcinoma is rising rapidly in Western countries. Considering that surgical resection is currently the major curative treatment, and that the 5-year survival rate highly depends on the p TNM stage at diagnosis, gastroesophageal adenocarcinoma management is very challenging for oncologists. Several treatment strategies are being evaluated, and among them systemic chemotherapy, to decrease recurrences and improve overall survival. The MAGIC and FNCLCCFFCD trials showed a survival benefit of perioperative chemotherapy in patients with operable gastric and lower esophageal cancer, and these results had an impact on the European clinical practice. New strategies, including induction chemotherapy followed by preoperative chemoradiotherapy, targeted therapies in combination with perioperative chemotherapy and the new cytotoxic regimens, are currently assessed to improve current standards and help developing patienttailored therapeutic interventions. | Emmanuelle Samalin Marc Ychou | 2016 | World Journal of Clinical Oncology2016，7，3： | 4 |
| 2 | Biweekly docetaxel, fluomuracil, lcucovorin, oxaliplatin (TEF) as first - line treatment for advanced gastric cancer and adenocarcinoma of the gastrocsopha- geal junction:safety and efficacy in a muhicenter cohort显示文摘 | PERNOT S MITRY E SAMALIN E | 2014 | Gastric Cancer2014，17，2： | 1 |
| 3 | Therapeutic improvements expected in the near future fbr sehizophrenia and schizoaltctive disorder: an appraisal of phase m clinical trials of schizophrenia- targeted therapies as found in US and EU clinical trial registries显示文摘 | GARAY RP CITROME L SAMALIN L et (d | 2016 | Expert Opin Pharmacother2016，17，7： | 1 |
| 4 | Neoadjuvant treatment in upper gastrointestinal adenocarcinomas:new paradigms from old concepts?显示文摘 | Ychou M | 2007 | Curr Opin Oncol2007，19，4： | 1 |
| 5 | The Role of the FOLFIRINOX Regimen for Advanced Pancreatic Cancer显示文摘 | Thierry Conroy Céline Gavoille Emmanuelle Samalin Marc Ychou Michel Ducreux | 2013 | Current Oncology Reports2013，，2： | 1 |
| 6 | Clinical potential of lurasidone in the management of schizophrenia显示文摘 | L Samalin Pierre-Michel Llorca Garnier | 2011 | Therapeutics and Clinical Risk Management2011，，： | 1 |
| 7 | Neoadjuvant treatment in upper gastrointestinal adenocarcinomas: new paradigms form old concepts?显示文摘 | Samalin E Ychou M | 2007 | Curr Opin Oncol2007，19，4： | 1 |
| 8 | Optimizing treatment of schizophrenia to minimize relapse显示文摘 | Samalin L Blanc O Llorca PM | 2010 | Expert Rev Neurother2010，10，2： | 1 |
| 9 | Efficacy of irino- tecan in combination with 5-fluorouracil (FOLFIRI) for me- tastatic gastric or gastroesophageal junction adenoearcinomas (MGA) treatment 显示文摘 | Samalin E Afchain P Thzenas S | 2011 | Clin Res Hepatol Gastroenterol2011，35，1： | 1 |
| 10 | The value of endoscopic rectal ultrasound in predicting the lateral clearance and outcome in patients with lower-third rectal ade- nocarcinoma 显示文摘 | Assenat E Thrzenas S Samalin E | 2007 | Endoscopy2007，39，4： | 1 |
| 11 | Atypical antipsychotic-induced mania/hypomania:a review of recent case reports and clinical studies显示文摘 | Benyamina A Samalin L | 2012 | Int J Psychiatry Clin Pract2012，16，1： | 1 |
| 12 | Sorafenib and irinotecan (NEXIRI) as second - or later - line treatment for patients with metastatic colorectal cancer and KRAS - mutated turnouts : A mul- ticentre phase I/II trial显示文摘 | Samalin E Bouche O Th6zenas S | 2014 | Br J Cancer2014，110，5： | 1 |
| 13 | Sorafenib and irinotecan(NEXIRI)as second-or later-line treatment for patients w ith metastatic colorectal cancer and KRAS-mutated tumours:amulticentre Phase I/II trial显示文摘 | Samalin E Bouche O Thezenas S | 2014 | Br J Cancer2014，110，5： | 1 |
| 14 | Biweekly docetaxel,fluorouracil,leucovorin,oxaliplatin(TEF)as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction:safety and efficacy in a multicenter cohort显示文摘 | Pernot S Mitry E Samalin E | | 0，，： | 1 |
| 15 | Optimizing treatment of schizophrenia to minimize relapse显示文摘 | Samalin L Blanc O Llorca PM | 2010 | Expert Rev Neurother2010，10，2： | 1 |
| 16 | Neoadjuvant treatment in upper gastrointestinal adenocarcinomas:new paradigms from old concepts显示文摘 | Samalin E Ychou M | 2007 | Curr Opin Oncol2007，19，： | 1 |
| 17 | Bevacizumab plus FOLFIRI or FOLFOX in chemotherapy-refractory patients with metastatic colorectal cancer:a retrospective study显示文摘 | Lievre A Samalin E Mitry E | | 0，，： | 1 |
| 18 | Colonic fiat neoplasia: frequency and concordance between endoscopic appearance and histologi- cal diagnosis in a French prospective series 显示文摘 | Diebold MD Samalin E Merle C | 2004 | Am J Gastroenterol2004，99，9： | 1 |
| 19 | Antidepressants in bipolar disorder 显示文摘 | Courtet P Samalin L Oli6 E | 2011 | Encephale2011，37，3： | 1 |
| 20 | The value of endoscopic recta/ultrasound in predicting the lateral clearance and out- come in patients with lower-third rectal adenoearcinoma显示文摘 | Assenat E Thezenas S Samalin E | 2007 | Endoscopy2007，39，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员